Orthofix Medical (NASDAQ:OFIX – Get Free Report) and Vicarious Surgical (NYSE:RBOT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations and valuation.
Insider and Institutional Ownership
89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by insiders. Comparatively, 9.5% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Orthofix Medical and Vicarious Surgical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Orthofix Medical | $822.31 million | 0.57 | -$92.19 million | ($1.51) | -7.75 |
| Vicarious Surgical | N/A | N/A | -$63.22 million | ($6.69) | -0.08 |
Vicarious Surgical has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Orthofix Medical has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500.
Profitability
This table compares Orthofix Medical and Vicarious Surgical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Orthofix Medical | -7.27% | -13.44% | -7.05% |
| Vicarious Surgical | N/A | -184.13% | -112.50% |
Analyst Ratings
This is a summary of recent ratings for Orthofix Medical and Vicarious Surgical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Orthofix Medical | 1 | 2 | 3 | 0 | 2.33 |
| Vicarious Surgical | 1 | 2 | 0 | 0 | 1.67 |
Orthofix Medical presently has a consensus price target of $17.25, indicating a potential upside of 47.50%. Vicarious Surgical has a consensus price target of $7.00, indicating a potential upside of 1,172.73%. Given Vicarious Surgical’s higher possible upside, analysts clearly believe Vicarious Surgical is more favorable than Orthofix Medical.
Summary
Orthofix Medical beats Vicarious Surgical on 7 of the 13 factors compared between the two stocks.
About Orthofix Medical
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
About Vicarious Surgical
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
